MetaCap

CryoPort Inc. Company Profile

NASDAQ: CYRXHealth CareBiotechnology: Pharmaceutical PreparationsUSD

17.35+0.45 (+2.66%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

CryoPort at a glance

CryoPort Inc. (NASDAQ: CYRX) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in Brentwood, TN. CryoPort is led by Mr. Jerrell W. Shelton and employs about 684 people. At a market capitalization of $878.8 million, it is considered a small-cap company.

Its SEC Central Index Key (CIK) is 0001124524, which identifies the company's filings on EDGAR.

Summary generated from market data by MetaCap's automated system. Methodology

What does CryoPort do?

Cryoport, Inc. provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and reproductive medicine markets worldwide. The company's Life Sciences Services segment provides temperature-controlled logistics and biostorage, bioservices and cryopreservation services within the life science industry. Its Life Sciences Products segment manufactures, and sells cryogenic freezers, cryogenic dewars, and related ancillary accessories within the life science industry through direct sales or a distribution network. The company's products include Cryoport Express Shippers; Cryoport Elite; Cryoport Express Cryogenic HV3 Shipping System; Smartpak Condition Monitoring System and Tec4Med, an IoT-based monitoring solutions; and Cryoport accessories. It also provides Cryoport BioStorage/Bioservices, such as Cryoport Systems Bioservices, including controlled temperature storage, kitting, labelling, fulfillment, sample management, drug return, and Qualified Person drug product release. In addition, the company offers IntegriCell services that comprise apheresis/leukapheresis collection, cryoshuttle transportation, cryo-process optimization, and cryopreservation services; Cryoport consulting services; MVE Fusion cryogenic system, a self-sustaining cryogenic freezer; and MVE Vario cryogenic system, a cryogenic freezer system. Further, it provides biological specimen cryopreservation storage and maintenance; archiving, monitoring, tracking, receipt, and delivery of samples; frozen biological specimens transportation; incoming and outgoing biological specimens management; and short-term logistics and engineering consulting services. The company was founded in 1999 and is based in Brentwood, Tennessee.

Business description based on the company's public filings.

Company information

Legal name
CryoPort Inc.
Ticker
NASDAQ: CYRX
Industry
Biotechnology: Pharmaceutical Preparations
CEO
Mr. Jerrell W. Shelton
Employees
684
Headquarters
112 Westwood Place, Brentwood, TN, United States
Phone
949 470 2300
Market cap
$878.76M
SEC CIK
0001124524

Companies similar to CryoPort

CYRX peer companies
CompanyPrice% ChgMarket capCompare
CRVSCorvus Pharmaceuticals Inc.10.52+3.04%$884.95Mvs CYRX
HELPHelus Pharma Inc.11.80+10.07%$862.11Mvs CYRX
ARDXArdelyx Inc.3.28+0.31%$846.86Mvs CYRX
JBIOJade Biosciences Inc.14.39+1.70%$915.17Mvs CYRX
RIGLRigel Pharmaceuticals Inc.49.08+0.74%$916.81Mvs CYRX
MLTXMoonLake Immunotherapeutics Class A10.82+2.27%$920.85Mvs CYRX
ALMSAlumis Inc.7.16+2.73%$926.76Mvs CYRX
AVBPArriVent BioPharma Inc.16.73+0.12%$824.92Mvs CYRX

Related